Colchicine for Patients With Coronary Artery Disease: A Systematic Review and Meta-analysis.
Shrestha Dhan B, Budhathoki Pravash, Sedhai YubRaj, +7 more·Journal of cardiovascular pharmacology
Several randomized controlled trials have studied the role of colchicine, a potent anti-inflammatory drug, to prevent adverse cardiovascular events in patients with coronary artery disease (CAD). In this meta-analysis, we aimed to determine the role of colchicine in patients with CAD in clinical outcomes and mortality.…